Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Dent Res. 2010 Apr 16;89(8):831–835. doi: 10.1177/0022034510368650

Figure 2.

Figure 2

Effect of azithromycin on GCF IL-1β and VEGF content. Arrows indicate the times azithromycin was administered. Data represent the mean (± SEM) recovery from samples obtained from twelve separate maxillary interproximal sites. The treatment effects on IL-1β and VEGF content were significant (P < 0.001, repeated measures ANOVA). Significant differences from baseline IL-1β is denoted by * and significant differences from baseline VEGF content is denoted by # (P < 0.05, Holm-Sidak test).